Related Experiment Video
Updated: Feb 5, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Center volume and post-transplant survival among adults with congenital heart disease
Jonathan N Menachem1, Joann Lindenfeld1, Kelly Schlendorf1
1Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Insights
Heart transplantation survival for adult congenital heart disease patients is lower at low-volume centers. Higher transplant center volume is associated with improved 30-day and 1-year survival rates for these patients.
Area of Science:
- Cardiology
- Transplantation Medicine
- Public Health
Background:
- The number of adult congenital heart disease (ACHD) patients requiring heart transplantation (HT) is increasing.
- While long-term survival post-HT is comparable to non-ACHD patients, 1-year survival remains lower for ACHD patients.
- Transplant center volume's impact on ACHD patient outcomes requires evaluation.
Purpose of the Study:
- To assess the association between heart transplant center volume and the 1-year survival of adult congenital heart disease patients.
- To compare survival rates at low-volume, medium-volume, and high-volume transplant centers for ACHD patients.
Main Methods:
- Analysis of United Network of Organ Sharing (UNOS) data for adult patients (≥18 years) undergoing their first orthotopic heart transplantation.
- Inclusion criteria: first orthotopic HT between January 1, 2000, and December 31, 2015.
- Stratification of transplant centers into low, medium, and high volume categories.
Main Results:
- 827 ACHD patients underwent HT at 113 centers during the study period.
- Low-volume centers had significantly lower 30-day (83%) and 1-year (75%) survival rates compared to medium (90%, 83%) and high-volume (91%, 84%) centers.
- A higher proportion of deaths within 30 days and 1 year occurred at low-volume centers.
Conclusions:
- Heart transplant center volume significantly influences 30-day and 1-year survival for ACHD patients.
- Low-volume centers demonstrate poorer outcomes compared to medium and high-volume centers.
- Further investigation into peri-operative care and multidisciplinary management at low-volume centers is warranted to improve survival.
Background:
The number of adult congenital heart disease (ACHD) patients requiring heart transplantation (HT) continues to grow, and if they survive the first year after transplant, their long-term survival is at least equivalent to non-ACHD patients. The 1-year survival of ACHD patients with HT remains lower than non-ACHD patients. We evaluated the affect of transplant center volume on 1-year survival of ACHD patients. We analyzed United Network of Organ Sharing patients (age ≥18 years) who underwent their first orthotopic HT between January 1, 2000, and December 31, 2015, to assess the association between transplant center volume and 1-year survival of ACHD patients.
Results:
We identified 827 ACHD patients at 113 centers who underwent HT during the study period. The average age of the recipients and donors was 36 ± 13 years (60% men and 84% Caucasian) and 28 ± 11 (63% men and 66% Caucasian), respectively. Of the ACHD patients undergoing HT, 27% (n = 60) were done at low-volume centers, 30% (n = 10) were reported at high-volume centers, and the remaining (n = 43) were at medium-volume centers. A total of 96 patients died within 30 days, including 37 (16.7%) at low-volume, 37 (10.2%) at medium-volume, and 22 (9.0%) at high-volume centers (p = 0.019). The average unadjusted Kaplan-Meier 30-day survival at low-volume centers was 83% ± 2%, which was significantly lower than medium-volume (90% ± 1%) and high-volume (91% ± 2%) centers (log-rank p < 0.05). Within 1 year, 154 patients had died, including 56 (36.4%) at low-volume, 60 (38.9%) at medium-volume, and 38 (24.7%) at high-volume centers (p = 0.011). Average unadjusted Kaplan-Meier 1-year survival at low-volume centers was 75% ± 3%, which was significantly lower than medium-volume (83% ± 2%) and high-volume (84% ± 2%) centers (log-rank p < 0.05).
Conclusions:
The 30-day and 1-year survival of ACHD patients undergoing HT is partly influenced by overall transplant center volume and, potentially, volume of ACHD HTs, with low-volume centers performing poorly relative to medium-volume and high-volume centers. The role of peri-operative care and multidisciplinary management in improving survival at low-volume centers required further investigations.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Lattice Centering and Coordination Number
Types of Unit Cells
Imagine taking a large number of identical...
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease IV: Nursing Management
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...

